Dr. Alan N. Engelman is a Professor in the Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. He received his PhD in 1990 from Tufts University School of Medicine and his postdoctoral training at the National Institute of Diabetes, Digestive, and Kidney Diseases. He holds additional appointments in the Center for Virology and Vaccine Research at the Beth Israel Deaconess Medical Center in Boston and is an Affiliated Faculty member at the Department of Microbiology, Harvard Medical School, in Boston. He joined DFCI in 1995; there, he conducts research on the mechanism of HIV-1 integration and teaches PhD candidates in the graduate program in virology at Harvard Medical School.